159 related articles for article (PubMed ID: 9050360)
1. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment.
Mohr DC; Goodkin DE; Likosky W; Gatto N; Neilley LK; Griffin C; Stiebling B
Mult Scler; 1996 Dec; 2(5):222-6. PubMed ID: 9050360
[TBL] [Abstract][Full Text] [Related]
2. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis.
Mohr DC; Goodkin DE; Likosky W; Gatto N; Baumann KA; Rudick RA
Arch Neurol; 1997 May; 54(5):531-3. PubMed ID: 9152109
[TBL] [Abstract][Full Text] [Related]
3. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.
Blake G; Murphy S
Neurology; 1997 Dec; 49(6):1747-8. PubMed ID: 9409387
[No Abstract] [Full Text] [Related]
4. [Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects].
Walther EU; Dietrich E; Hohlfeld R
Nervenarzt; 1996 Jun; 67(6):452-6. PubMed ID: 8767199
[TBL] [Abstract][Full Text] [Related]
5. Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.
Chellingsworth M
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939140
[No Abstract] [Full Text] [Related]
6. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.
Petkau J; White R
Mult Scler; 1997 Dec; 3(6):402. PubMed ID: 9493643
[No Abstract] [Full Text] [Related]
7. Nursing management of MS patients receiving interferon beta-1b therapy.
Costello K; Conway K
Rehabil Nurs; 1997; 22(2):62-6, 81. PubMed ID: 9110845
[TBL] [Abstract][Full Text] [Related]
8. Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.
Longthorne PN
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939141
[No Abstract] [Full Text] [Related]
9. Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.
Cardy P
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939142
[No Abstract] [Full Text] [Related]
10. Treatment of multiple sclerosis with interferon beta-1 b.
Abdul-Ahad A; Shah S; Galazka A
Neurology; 1997 Aug; 49(2):641-2. PubMed ID: 9270626
[No Abstract] [Full Text] [Related]
11. Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b.
Schwid SR; Goodman AD; Mattson DH
Arch Neurol; 1997 Sep; 54(9):1169-90. PubMed ID: 9311363
[TBL] [Abstract][Full Text] [Related]
12. [A wide support of patients with multiple sclerosis promotes success of long-term therapy].
Sidorenko TV; Khachanova NV; Boĭko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Spec No 3():96-100. PubMed ID: 17172243
[TBL] [Abstract][Full Text] [Related]
13. Interferon beta in multiple sclerosis.
Richards RG
BMJ; 1996 Nov; 313(7066):1159. PubMed ID: 8916730
[No Abstract] [Full Text] [Related]
14. [Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland].
Huber S; Spycher M; Lechner-Scott J; Bellaiche Y; Steck AJ; Kappos L
Schweiz Med Wochenschr; 1996 Aug; 126(35):1475-81. PubMed ID: 8927950
[TBL] [Abstract][Full Text] [Related]
15. Why interferon beta 1b was licensed is a mystery.
Harvey P
BMJ; 1996 Aug; 313(7052):297-8. PubMed ID: 8704553
[No Abstract] [Full Text] [Related]
16. [Immunotherapy of multiple sclerosis. Consensus and controversies].
Hohlfeld R
Nervenarzt; 1999 Apr; 70(4):297. PubMed ID: 10354989
[No Abstract] [Full Text] [Related]
17. Interferon beta treatment for multiple sclerosis: persisting questions.
Goodkin DE
Mult Scler; 1996 Jul; 1(6):321-4. PubMed ID: 9345408
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.
Webster GF; Knobler RL; Lublin FD; Kramer EM; Hochman LR
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):365-7. PubMed ID: 8655728
[TBL] [Abstract][Full Text] [Related]
19. Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis.
Mohr DC; Goodkin DE; Masuoka L; Dick LP; Russo D; Eckhardt J; Boudewyn AC; Bedell L
Mult Scler; 1999 Jun; 5(3):192-7. PubMed ID: 10408720
[TBL] [Abstract][Full Text] [Related]
20. Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a.
Mohr DC; Likosky W; Boudewyn AC; Marietta P; Dwyer P; Van der Wende J; Goodkin DE
Mult Scler; 1998 Dec; 4(6):487-9. PubMed ID: 9987757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
